Company profile

OncoCell MDx company profile

OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, They have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of their pipeline.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2012-01-01

Headquarters

Headquarters
Corvallis, Oregon, United States
Postal code
97330
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$22.2M
Last funding
Series B / $22.2M / 2019-09-11
Last equity funding
Series B / $22.2M
Investors
1
Lead investors
1
Founders
1

Categories and groups

No public categories are available.

Founders and investors

Founders

Harry Stylli

Lead investors

Savitr Capital

Investors

Savitr Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.